Synthesis and evaluation of dopaminergic prodrugs designed for transdermal iontophoretic drug delivery. Highly water-soluble amino acid ester prodrugs applicable for the treatment of Parkinson’s disease
PhD ceremony: Mr. J. de Graan, 14.30 uur, Academiegebouw, Broerstraat 5, Groningen
Dissertation: Synthesis and evaluation of dopaminergic prodrugs designed for transdermal iontophoretic drug delivery. Highly water-soluble amino acid ester prodrugs applicable for the treatment of Parkinson’s disease
Promotor(s): prof. B.H.C. Westerink
Faculty: Mathematics and Natural Sciences
Dopamine agonists are used as pharmacotherapy for patients with Parkinson's disease. In his thesis Jeroen de Graan describes the preparation and evaluation of highly water-soluble derivatives of the dopamine agonist 5-OH-DPAT. These derivatives are chemically coupled compounds of 5-OH-DPAT with other molecules, i.e. amino acids. In pharmacy these compounds are named prodrugs. A prodrug is a non-pharmacologically active compound which will release the active drug after conversion in the body.
De Graan's research has led to several findings. First, highly water-soluble prodrugs were synthesized which showed sufficient stability while in solution in the iontophoretic patch (sufficient sustainability), but released the drug on entry in the bloodstream. Second, by coupling 5-OH-DPAT to dipeptides (two combined amino acids) he obtained even more stable prodrugs. Third, 5-OH-DPAT could be administered in a controlled manner, which would facilitate the development of a feedback system. Finally, he found that the iontophoretic delivery of a highly water-soluble prodrug of 5-OH-DPAT led to a prolongation of the pharmacological effect in comparison to 5-OH-DPAT itself.
These results show that the application of prodrugs can be advantageous for the administration of dopamine agonists and other drugs by transdermal iontophoresis. Further research of this pharmaceutical dosage form could eventually lead to a new pharmacotherapy of patients with Parkinson's disease.
Last modified: | 13 March 2020 01.02 a.m. |
More news
-
29 August 2025
Top Dutch Solar Racing stranded just before the finish line, but returns proudly
From August 24 to 31 this year, the student team Top Dutch Solar Racing will participate in the Bridgestone World Solar Challenge. This page will keep you up to date on the latest developments during and around the race.
-
21 August 2025
Upconversion nanoparticles to aid the application of molecular motors
Scientists from Groningen University and the University of Amsterdam have developed upconversion nanoparticles to assist in powering molecular motors.
-
19 August 2025
Bruno Ehrler appointed new director of AMOLF
Honorary professor Bruno Ehrler of the University of Groningen has been appointed as the new director of AMOLF, the NWO Institute for research into functional complex matter.